Orient Pharma Co., Ltd.(TW:4166)
NT$22.55+0.05 (+0.22%)
TW:4166
Orient Pharma Co., Ltd. earnings date
NT$22.55
At close:+0.05 (+0.22%)
Orient Pharma Co., Ltd. (4166) Q2 2026 Earnings Report
TW:4166 Q2 2026 EPS Results
- Actual EPS
- TWD 0.24
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- TWD 0.08
TW:4166 Q2 2026 Revenue Results
- Actual Revenue
- TWD 427.08M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +31.19%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- TBA
- Conference Call
- Tuesday, August 11, 2026
TW:4166 Upcoming Earnings
Orient Pharma Co., Ltd.'s next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:4166 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | ―0.31 | 0.21 | 49.52% (+0.10) | ― |
| Aug 11, 2026 | 2026 (Q2) | ―0.24 | 0.08 | 180.95% (+0.15) | |
| May 13, 2026 | 2026 (Q1) | ―0.16 | 0.23 | -29.96% (-0.07) | |
| Feb 25, 2026 | 2025 (Q4) | ―0.38 | 0.05 | 721.74% (+0.33) | |
| Nov 11, 2025 | 2025 (Q3) | ―0.21 | 0.43 | -51.72% (-0.23) | |
| Aug 13, 2025 | 2025 (Q2) | ―0.08 | 0.43 | -80.69% (-0.35) | |
| May 14, 2025 | 2025 (Q1) | ―0.23 | 0.1 | 129.29% (+0.13) | |
| Mar 24, 2025 | 2024 (Q4) | ―0.05 | 0.1 | -53.54% (-0.05) | |
| Aug 13, 2024 | 2024 (Q2) | ―0.43 | 0 | 43400.00% (+0.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
